Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (68)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- A single-gene disorder with multisystem consequences
- Chloride transport is not the only CFTR function
- Classes IV–VI: Residual or unstable function
- Other respiratory complications extend the differential
- Fat-soluble vitamin deficiencies are predictable
- Salivary gland changes resemble pancreatic changes
- Potentiators versus correctors
- Source and scope
Slide index & full transcript (68 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Cystic Fibrosis (Mucoviscidosis)
Molecular mechanism · organ pathology · clinicopathologic diagnosis
Pathology lecture
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning outcomes
Explain how CFTR dysfunction alters epithelial ion and fluid transport.
Relate viscous secretions to structural injury in lung, pancreas, intestine, and hepatobiliary tract.
Recognize the clinical spectrum, diagnostic logic, and genotype-dependent variation.
Distinguish supportive care from mechanistically targeted CFTR treatments.
Slide 3 · A single-gene disorder with multisystem consequences
Autosomal recessive disorder of epithelial ion transport.
Affects exocrine glands and respiratory, gastrointestinal, and reproductive epithelia.
Thickened secretions obstruct ducts and airways.
Clinical effects arise from obstruction, infection, inflammation, and impaired secretion.
CFTR dysfunction
Altered salt + water movement
Multiorgan complications
Slide 4 · Why “mucoviscidosis” describes the phenotype
Viscous, poorly hydrated secretions accumulate within epithelial passages.
Mechanical obstruction compromises secretion drainage.
Retained secretions predispose to inflammation and secondary infection.
Manifestations depend on which ductal system is affected.
Altered epithelial fluids
Luminal plugging
Secondary organ injury
Slide 5 · Clinical expression is heterogeneous
Onset ranges from prenatal or neonatal disease to childhood, adolescence, and adulthood.
Some individuals present with classic multisystem disease.
Others exhibit comparatively mild or organ-limited manifestations.
Variation reflects CFTR alleles, tissue physiology, and modifier effects.
Classic CF
Pancreas-sufficient CF
Late-onset pulmonary disease
Isolated reproductive phenotype
Slide 6 · Transmission follows an autosomal recessive pattern
Two parental CFTR alleles
Biallelic pathogenic variants
Reduced epithelial CFTR function
Characteristic organ phenotypes
Affected individuals carry disease-causing variants in both alleles.
Different variant combinations alter residual CFTR function and the clinical phenotype.
Slide 7 · Historical epidemiologic context
An incidence of approximately 1 in 2,500 live births among people of Northern European descent.
The source reports a U.S. Carrier frequency of approximately 1 in 20 in that ancestry group.
CFTR variants occur globally, with substantial population differences.
These textbook figures are ancestry-specific historical estimates, not universal contemporary rates.
Slide 8 · One molecular defect, different tissue responses
Respiratory / intestinal epithelium
Reduced anion secretion
Dehydrated surface fluid
Mucus stasis and obstruction
Sweat duct epithelium
Reduced salt reabsorption
Excess NaCl remains in sweat
High sweat chloride
Slide 9 · CFTR is an epithelial anion channel
CFTR gene is located on chromosome 7q31.2.
The encoded protein forms an apical membrane ion channel.
Its primary relevant substrates are chloride and bicarbonate ions.
It also regulates interacting ion channels and secretory processes.
Schematic: Apical membrane
Lumen
CFTR
Cytoplasm
Cl⁻ / HCO₃⁻ secretion
Transport directed toward the lumen
Slide 10 · The CFTR protein has modular architecture
Two membrane-spanning domains
Two nucleotide-binding domains
Regulatory (R) domain
The membrane domains form the ion-conducting pore.
ATP handling at nucleotide-binding domains controls channel gating.
Phosphorylation of the R domain promotes channel opening.
Slide 11 · Cyclic AMP controls channel activation
Agonist → ↑ cAMP
Protein kinase A activation
R-domain phosphorylation
ATP-dependent channel gating
The channel is not a permanently open hole; Regulatory signals coordinate its operation.
Disruptions in gating can cause disease even if the protein reaches the membrane.
Slide 12 · Chloride transport is not the only CFTR function
CFTR conducts HCO₃⁻ as well as Cl⁻.
It interacts with epithelial sodium channel (ENaC).
CFTR-linked transport helps set the hydration and chemistry of surface secretions.
Abnormal bicarbonate transport favors acidic, poorly soluble mucus.
Schematic: Apical membrane
Lumen
CFTR
Cytoplasm
Cl⁻ / HCO₃⁻ secretion
Transport directed toward the lumen
Slide 13 · Normal airway fluid supports mucociliary clearance
Apical anion secretion
Appropriate surface water layer
Cilia mobilize mucus
Microorganisms are cleared
Water content and ciliary movement cooperate to clear inhaled material.
The airway surface fluid layer is physiologically important even when its salt concentration is unchanged.
Slide 14 · CF airways lose surface-fluid volume
↓ Cl⁻ secretion
↑ ENaC-mediated Na⁺ uptake
↑ passive water reabsorption
Dehydrated airway secretions
An isotonic but low-volume airway surface layer.
The dominant physiologic lesion is dehydration of mucus, not simply excessive airway salt concentration.
Slide 15 · Airway mucus becomes difficult to clear
Water loss concentrates airway mucus.
Ciliary activity becomes ineffective against dense secretions.
Mucus obstructs bronchi and bronchioles.
Stagnant secretions facilitate bacterial persistence.
Schematic bronchial lumen
Inspissated mucus
Obstruction + infection
Slide 16 · The sweat duct behaves in the opposite direction
Normal sweat ducts reabsorb luminal chloride and associated sodium.
CFTR dysfunction reduces ductal NaCl reclamation.
Sweat therefore contains increased electrolyte concentrations.
Sweat glands show no characteristic structural abnormality despite the transport defect.
Schematic: Sweat duct lumen
Na⁺ + Cl⁻ stay in lumen
Elevated sweat salt
Normal gland morphology
Slide 17 · Bicarbonate defects promote ductal plugging
↓ HCO₃⁻ transport
Lower ductal secretion pH
Increased mucin precipitation
Obstructed exocrine ducts
CFTR interacts with SLC26-family anion exchangers.
Some variants preserve chloride transport relatively well while markedly disrupting bicarbonate transport.
Slide 18 · Salt elevation and mucus dehydration are not contradictions
Sweat duct
Normal role: Electrolyte reabsorption
CF: NaCl remains in the lumen
Phenotype: Salty sweat
Airway / intestine
Normal role: Luminal anion secretion
CF: Water depleted from luminal fluid
Phenotype: Thickened secretions
Slide 19 · Different organs share a duct-obstruction mechanism
Defective epithelial anion transport
Abnormal luminal secretions
Ductal / airway plugging
Atrophy, infection, or fibrosis
The final tissue response depends on local anatomy and function.
Some tissues primarily develop destructive inflammation; Others lose secretory parenchyma.
Slide 20 · More than one molecular mechanism causes CF
Variants alter the amount, localization, gating, conductance, or stability of CFTR.
The source describes six functional mutation classes.
Different classes leave different amounts of residual channel activity.
Functional classes explain disease mechanisms but do not fully predict severity in every organ.
Absent synthesis
Misfolding / trafficking
Gating failure
Reduced channel activity
Slide 21 · Classes I–III: Severe reduction in function
Class
Principal defect
Consequences
I
No protein synthesis
No apical CFTR
II
Misfolding / trafficking
Degradation before surface delivery
III
Defective gating
Membrane protein with poor opening
Slide 22 · Classes IV–VI: Residual or unstable function
Class
Principal defect
Consequences
IV
Reduced conductance
Reduced ion flow through pore
V
Reduced production
Decreased amount of near-normal CFTR
VI
Membrane instability
Accelerated loss from surface
Slide 23 · Phe508del illustrates defective processing
Deletion of Phe508
Impaired folding of CFTR
Retention / degradation
Near-absent surface CFTR
Also historically written ΔF508; It is a class II processing variant.
Protein quantity at the membrane falls because of impaired maturation and trafficking.
Slide 24 · Gating and conductance are distinct failures
Class III: Gating
Protein may reach apical surface
Opening response is defective
Example in source: Gly551Asp
Class IV: Conductance
Protein may reach apical surface
Ion flux through open pore is reduced
Example in source: Arg117His
Slide 25 · Genotype predicts pancreatic disease better than lung disease
Two severely impaired alleles commonly produce pancreatic-insufficient classic CF.
One allele with residual function may preserve exocrine pancreatic output.
Pulmonary severity depends more heavily on environmental and genetic modifiers.
Identical CFTR genotypes need not produce identical pulmonary trajectories.
CFTR genotype
Residual channel function
Tissue-specific phenotype
Slide 26 · Modifier effects broaden the phenotype
CFTR variants
Modifier loci
Environmental exposures
Observed disease severity
MBL2, TGFB1, and IFRD1 as example modifier loci.
Intercurrent viral and chronic bacterial infections influence lung disease progression.
Slide 27 · The lung develops a self-perpetuating injury cycle
Mucus retention
Airway bacterial persistence
Inflammation and tissue injury
Worsening clearance
Obstructed airways create conditions that favor further infection.
Inflammatory damage can amplify obstruction and chronic structural lung disease.
Slide 28 · Chronic infection is not just an acute exacerbation
Impaired clearance permits intermittent and then chronic colonization.
Pseudomonas aeruginosa is particularly important in progressive lung disease.
Persistent organisms may establish biofilms that resist host defense.
Recurrent infection and inflammation ultimately distort airway architecture.
Impaired clearance
Chronic colonization
Bronchiectasis / damage
Slide 29 · Pseudomonas biofilm impedes clearance
Stagnant hypoxic mucus
Alginate production
Mucoid bacterial biofilm
Protected persistence
The alginate-rich phenotype is associated with chronic infection.
Host antibody and cellular responses may add injury without eliminating embedded bacteria.
Slide 30 · Airway pathogens have clinical significance
Organism
Pathologic significance
Staphylococcus aureus
Recurrent airway infection
Haemophilus influenzae
Recurrent airway infection
Pseudomonas aeruginosa
Mucoid chronic colonization; biofilm
Burkholderia cepacia complex
Potential severe progressive infection
Slide 31 · Other respiratory complications extend the differential
Robbins also identifies Stenotrophomonas maltophilia and nontuberculous mycobacteria as opportunistic pathogens.
Allergic bronchopulmonary aspergillosis occurs with increased frequency.
Burkholderia cenocepacia may cause severe illness within the B. Cepacia complex.
Microbiology must be interpreted with the chronic bronchiectatic setting in mind.
Slide 32 · Early pulmonary morphology: Impacted bronchioles
Thick mucus distends the bronchiolar lumen.
Mucus-producing epithelial cells undergo hypertrophy and hyperplasia.
Luminal obstruction impairs distal ventilation and clearance.
Secondary infection intensifies epithelial and tissue injury.
Schematic bronchial lumen
Inspissated mucus
Obstruction + infection
Slide 33 · Advanced pulmonary morphology: Bronchiectasis
Chronic mucus plugging
Neutrophilic / infectious injury
Airway wall destruction
Permanent bronchial dilation
The text describes chronic bronchitis, bronchiectasis, and sometimes lung abscesses.
Anatomical damage becomes an independent obstacle to effective clearance.
Slide 34 · Pulmonary findings connect mechanism to symptoms
Mechanism / lesion
Clinical association
Mucus plugging
Chronic cough, sputum, wheezing
Airway obstruction
Air trapping, hyperinflation
Bronchiectasis / infection
Persistent radiographic changes
Chronic pulmonary disease
Clubbing, cardiopulmonary complications
Slide 35 · Sinus disease belongs to the CF phenotype
Chronic sinonasal disease is a characteristic extrapulmonary airway manifestation.
Nasal polyps are included among recognized clinical features.
Persistent sinus abnormalities can coexist with bronchial disease.
Organ-specific symptoms may precede recognition of multisystem CF.
Chronic sinusitis
Nasal polyps
Bronchiectasis
Airway infections
Slide 36 · Pulmonary disease drives major late complications
Chronic airway injury
Obstructive lung disease
Pulmonary vascular strain
Cor pulmonale
The text identifies cardiorespiratory complications as a major cause of mortality.
Lung disease severity is influenced by organisms, host inflammation, and modifiers.
Slide 37 · The pancreas is frequently structurally involved
Pancreatic lesions occur in most individuals with classic CF.
Mild involvement may begin as mucus accumulation and duct dilation.
Severe lesions show acinar destruction and progressive fibrosis.
At an advanced stage, islets may persist within fibrofatty stroma.
Schematic: Exocrine pancreas
Mucus-filled ducts → acinar loss
Fibrofatty replacement
Slide 38 · How duct obstruction destroys the exocrine pancreas
Thick intraductal secretions
Outflow obstruction
Acinar atrophy / loss
Fibrofatty replacement
Impaired enzyme delivery contributes to malabsorption.
Morphologic severity varies markedly across CFTR genotypes.
Slide 39 · Pancreatic insufficiency impairs nutrient absorption
Reduced exocrine enzymes
Fat and protein maldigestion
Steatorrhea / nutritional losses
Poor weight gain
Large, foul-smelling stools and abdominal distention may begin during infancy.
Pancreatic disease explains much of the failure-to-thrive phenotype.
Slide 40 · Fat-soluble vitamin deficiencies are predictable
Deficiency
Clinicopathologic significance
Vitamin A
Deficiency may contribute to epithelial changes
Vitamin D
Reduced fat-soluble vitamin availability
Vitamin E
Vitamin depletion with chronic malabsorption
Vitamin K
Vitamin depletion with chronic malabsorption
Slide 41 · Not every patient requires pancreatic enzymes
Pancreatic-insufficient CF
Often two severe alleles
Steatorrhea / failure to thrive
Substantial acinar destruction
Pancreas-sufficient CF
Residual CFTR activity may persist
Better growth and absorption
Pancreatitis may still occur
Slide 42 · Pancreatitis can signal less complete CFTR loss
Some pancreas-sufficient individuals develop recurrent pancreatitis.
Recurrent episodes may manifest with acute abdominal pain.
CFTR-associated chronic pancreatitis may occur without classic multisystem CF.
Interpret isolated pancreatic disease in the context of genotype and physiology.
Residual duct function
Recurrent pancreatic injury
Pancreatitis phenotype
Slide 43 · Pancreatic injury may also affect islet function
Progressive parenchymal destruction can involve the endocrine pancreas.
Cystic-fibrosis-related diabetes occurs in a subset of affected adults.
Exocrine insufficiency and endocrine dysfunction are related but distinct consequences.
The clinical presentation depends on extent and duration of pancreatic injury.
Schematic: Exocrine pancreas
Mucus-filled ducts → acinar loss
Fibrofatty replacement
Slide 44 · Meconium ileus is an early diagnostic clue
Abnormal intestinal secretion
Inspissated meconium
Small-bowel obstruction
Neonatal presentation
Neonatal meconium ileus as an initial presentation in a minority of cases.
The obstruction is a consequence of abnormal luminal secretions, not a primary muscle disorder.
Slide 45 · Distal intestinal obstruction can recur later
Older patients may have episodes of distal intestinal obstruction syndrome.
A typical syndrome includes right lower quadrant pain.
A palpable meconium mass may be present in the right iliac fossa.
Intussusception can occur in association with obstruction.
Thick intestinal contents
Distal bowel obstruction
Right iliac fossa symptoms
Slide 46 · Additional gastrointestinal manifestations
Persistent malabsorptive diarrhea may contribute to rectal prolapse.
Loss of protein can cause marked hypoproteinemia and generalized edema.
Intestinal phenotypes are most pronounced when pancreatic exocrine secretion is inadequate.
Relatively pancreas-sufficient individuals often have better nutritional outcomes.
Slide 47 · CF hepatobiliary disease begins with secretion obstruction
Thick bile / ductal plugging
Ductular proliferation
Portal inflammation
Focal biliary fibrosis
Hepatic steatosis may coexist.
A subset progresses to focal or diffuse biliary cirrhosis.
Slide 48 · Cystic fibrosis liver disease is variable
Focal biliary cirrhosis may arise after chronic biliary injury.
Severe diffuse cirrhotic disease affects a minority of patients.
Clinical or biochemical liver abnormalities may emerge later in life.
Bile-duct sludge or stones can produce acute pain and jaundice.
Biliary duct plugging
Portal fibrosis
Cirrhosis in a subset
Slide 49 · Salivary gland changes resemble pancreatic changes
Ductal mucus retention
Duct dilation
Epithelial metaplasia
Gland atrophy and fibrosis
Squamous metaplasia of ductal epithelial lining.
Shared ductal anatomy explains similar injury responses in multiple exocrine glands.
Slide 50 · Male reproductive findings can dominate presentation
Congenital bilateral absence of the vas deferens is characteristic.
Obstructive azoospermia causes infertility in most affected adult males.
In some individuals this may be the only clinical indication of a CFTR-associated disorder.
An otherwise limited reproductive phenotype does not exclude CFTR variants.
CFTR variants
Vas deferens abnormality
Obstructive azoospermia
Slide 51 · Classic versus nonclassic cystic fibrosis
Classic phenotype
Sinopulmonary involvement
Pancreatic insufficiency common
Multiorgan features often coexist
Nonclassic phenotype
Later or limited presentation
Residual CFTR function often present
May involve pancreas, lung, or vas deferens
Slide 52 · Common clinical feature clusters
System
Findings in Robbins
Airways
Chronic cough, sputum, infections, bronchiectasis
GI / nutrition
Meconium ileus, steatorrhea, poor growth
Hepatobiliary
Chronic liver disease or biliary cirrhosis
Sweat / salt
Elevated sweat chloride; salt depletion
Reproduction
Congenital bilateral absent vas deferens
Slide 53 · Clinical suspicion arises from phenotype or screening
Typical clinical feature
Family history / relative
Newborn screen positive
Confirm CFTR dysfunction
Characteristic multisystem findings raise pretest probability.
A positive screen is an entry point for confirmation, not a final diagnosis.
Slide 54 · Newborn screening measures pancreatic injury
Immunoreactive trypsinogen in blood as a common screening analyte.
Pancreatic injury may elevate the measured concentration.
A positive result requires appropriate confirmatory testing.
Screening assesses risk; It does not directly prove altered epithelial ion transport.
Raised IRT screen
Clinical follow-up
Confirmatory CF testing
Slide 55 · Sweat chloride reflects duct transport physiology
Loss of CFTR-mediated salt reclamation raises sweat NaCl.
The sweat test is grounded in a disease-specific transport defect.
Textbook diagnostic criteria combine phenotype/screening with objective CFTR dysfunction.
Atypical variants may yield borderline or near-normal sweat concentrations.
Schematic: Sweat duct lumen
Na⁺ + Cl⁻ stay in lumen
Elevated sweat salt
Normal gland morphology
Slide 56 · Diagnostic evidence has complementary roles
Approach
What it contributes
Clinical phenotype / family
Raises suspicion or pretest probability
Immunoreactive trypsinogen
Newborn screening signal
Sweat chloride
Evidence of impaired sweat-duct ion transport
CFTR variant analysis
Identification of disease-causing variants
Functional electrophysiology
Nasal or intestinal CFTR functional evidence
Slide 57 · Interpret intermediate or discordant tests cautiously
Suggestive history / screen
Sweat chloride assessment
Genetic evaluation
Functional tests if needed
Robbins reproduces a diagnostic framework allowing complementary evidence.
Do not assume that all CFTR sequence variants are disease-causing or that one normal test rules out atypical disease.
Slide 58 · Molecular therapy targets the causal protein defect
Conventional treatment addresses infection, nutrition, and organ complications.
CFTR-directed therapies act on the protein itself.
Eligibility depends on disease-causing variant and molecular behavior.
Robbins groups CFTR agents into potentiators, correctors, and amplifiers.
CFTR defect
Mutation-matched approach
Improved protein function
Slide 59 · Potentiators versus correctors
Potentiators
Improve channel opening
Especially relevant to gating defects
Require surface-available CFTR
Correctors
Support folding / processing
Increase membrane CFTR delivery
Relevant to processing defects
Slide 60 · Amplifiers represent a different intervention point
CFTR gene expression
CFTR protein abundance
Function at cell surface
Epithelial ion transport
Amplifiers as agents intended to increase CFTR protein production.
More protein alone may not repair a defective gating or trafficking mechanism.
Slide 61 · Supportive treatment remains organ-directed
Clinical problem
Management strategy described
Recurrent airway infection
Antimicrobial therapy
Pancreatic insufficiency
Pancreatic enzyme replacement
Severe end-stage lung disease
Bilateral lung transplantation
Specific CFTR variants
Targeted modulator combination therapy
Slide 62 · Integrated case: Neonatal obstruction
Clinical problem
A newborn develops intestinal obstruction from unusually thick meconium.
The family reports unusually salty sweat in an affected sibling.
Consider how an epithelial transport defect could explain both findings.
Mechanistic interpretation
Meconium ileus suggests intestinal secretion abnormality; Defective sweat-duct salt reabsorption provides the parallel diagnostic clue.
Slide 63 · Integrated case: Recurrent pulmonary infection
Clinical problem
An adolescent has productive cough, recurrent infections, and bronchiectasis.
Airway cultures repeatedly yield mucoid Pseudomonas aeruginosa.
Explain how impaired CFTR function favors this chronic infection pattern.
Mechanistic interpretation
A dehydrated mucus layer impairs clearance; Stagnant hypoxic secretions favor alginate-rich biofilm and ongoing airway damage.
Slide 64 · Integrated case: Pancreatic-sufficient phenotype
Clinical problem
An adult has recurrent idiopathic pancreatitis and no prominent steatorrhea.
CFTR-related disease is considered despite relatively preserved nutrition.
Explain why a milder or organ-limited CFTR phenotype is plausible.
Mechanistic interpretation
Residual channel function may preserve exocrine output while permitting episodic ductal injury; Pulmonary and pancreatic severity need not parallel each other.
Slide 65 · Four causal links explain the clinical syndrome
CFTR ion transport
Secretion hydration / pH
Obstruction and infection
Organ failure phenotype
The same mutation can produce contrasting sweat and airway electrolyte effects.
Pulmonary, pancreatic, biliary, intestinal, and reproductive lesions follow tissue-specific consequences.
Slide 66 · Pathology synthesis
Respiratory tract: Mucus plugging, chronic infection, bronchiectasis, and pulmonary complications.
Pancreas: Ductal obstruction, exocrine acinar loss, fibrosis, and malabsorption.
Intestine and biliary tree: Thick secretions, obstruction, and possible progressive liver injury.
Reproductive tract: Congenital bilateral absence of vas deferens and obstructive azoospermia.
Sweat glands: Characteristic functional electrolyte defect without structural lesion.
Slide 67 · Diagnostic synthesis and clinical reasoning
Recognize a constellation of sinopulmonary disease, pancreatic or intestinal disease, and characteristic reproductive findings.
Use newborn screening or phenotype to initiate—not conclude—diagnosis.
Confirm CFTR dysfunction through complementary sweat, molecular, or epithelial functional evidence.
Relate phenotype to residual CFTR function, tissue physiology, and modifier effects.
Slide 68 · Source and scope
Principal textbook
Robbins, Cotran & Kumar: Pathologic Basis of Disease
11th edition (2026) · Diseases of Infancy and Childhood
Cystic Fibrosis and adjacent CFTR mechanism, morphology, and clinical-feature sections
The presentation uses original editable schematics. No textbook micrographs or scanned textbook figures are reproduced.